Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



@@#116300@@

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le samedi 9 novembre 2019
Doi : 10.1016/j.jaad.2019.07.090
JAAD Game Changers: Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial
 

Adam J. Friedman, MD
 Washington, District of Columbia 

Correspondence to: Adam J. Friedman, MD, George Washington School of Medicine and Health Sciences, Department of Dermatology, 2150 Pennsylvania Ave, NW, Washington, DC 20037.George Washington School of Medicine and Health SciencesDepartment of Dermatology2150 Pennsylvania Ave, NWWashingtonDC20037.

 A game changer is a short narrative stating how an article that originally appeared in JAAD  changed the game of dermatology. NOTE: The Game Changer author is not the original author of the article. Please see the reference section for the original author information.
 Funding sources: None.
 Conflicts of interest: None disclosed.


Top of the page

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@